Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Arch Biochem Biophys. 2012 Oct 19;535(1):22–29. doi: 10.1016/j.abb.2012.10.005

Fig. 6.

Fig. 6

PKCβII inhibition reduces TnI and MLC2 phosphorylation. ProQ results showing phosphorylation status of myofilament proteins troponin-I (TnI) and myosin light chain-2 (MLC2) with or without PKCβII peptide inhibitor I trifluoroacetate salt administration to induce inhibition of PKCβII at a short (muscle slacked) and long (optimal) muscle length.